Sign in
Taking peopleNo phase

Effect of Diluent Volume on Colistin Inhalation Therapy

Key facts

Who runs it
Fu Jen Catholic University
Where
Taiwan1 site in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
60 people, planned
Started
10 Mar 2024
Expected to end
31 Dec 2027
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Colistin 1 MU in normal saline 1 ml
  • Colistin 1 MU in normal saline 2 ml
Record updated
9 November 2026

Who can take part

Age
18 years to 100 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 6 criteriaShow less

Who can take part

  • Admitted to the Intensive Care Unit
  • Age greater than 18 years and using a ventilator due to acute respiratory failure
  • Requires inhalation colistin treatment as determined by the disease
  • Sign the written informed consent form

Who cannot take part

  • Receiving both inhaled colistin and intravenous colistin treatments
  • Renal failure requiring renal dialysis

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 18 and 100 years old?

This trial is currently available in Taiwan.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The aim of this study is to investigate the impact of different diluent volumes for the same dosage of colistin in mechanically ventilated respiratory patients receiving colistin inhalation therapy. The study aims to determine whether the diluent volume has an effect on clinical outcomes, including ICU length of stay, total hospitalization duration, duration of respiratory support within 28 days, mortality rates within 28 days and 90 days, as well as analyze the pharmacokinetic profile of colistin in blood and bronchoalveolar lavage fluid. Additionally, the study will evaluate the incidence of nebulizer malfunctions and blockages. The findings of this research will help identify the optimal diluent volume for colistin inhalation therapy in clinical practice.

The 2 groups in the trial

  • Colistin 1 MU in normal saline 1 mlExisting treatment, for comparison

    1 MU of colistin in a total volume of 6 ml, diluted with a 1:1 ratio in normal saline (0.9%)

  • Colistin 1 MU in normal saline 2 mlTreatment being tested

    1 MU of colistin in a total volume of 12 ml, diluted with a 1:2 ratio in normal saline (0.9%)

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Effect of Diluent Volume on Colistin Inhalation Therapy for Mechanically Ventilated Respiratory Patients
Criteria questions
Built from NCT06230614, who can take part
Record updated
9 November 2026